C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2004
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485377A1 Pyranones useful as atm inhibitors
12/15/2004	EP1485376A1 Compositions useful as inhibitors of protein kinases
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485363A1 Cyclic amides
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485093A1 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1284267B1 Triazole compounds having amide linkage
12/15/2004	EP1218005B1 Vitronectin receptor antagonists
12/15/2004	EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/15/2004	EP0863755B1 Antithrombotic diamines
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555260A Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179955C Methodfor the preparation of taxol and its derivatives
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179945C Indole derivatives, process for preparation of same and use thereof
12/15/2004	CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	US6831088 3-heterocyclypropanohydroxamic acid PCP inhibitors
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831039 3-(heterocyclyl)-substituted benzolpyrazols
12/13/2004	CA2470935A1 Polyene oxazoles and processes for their preparation
12/09/2004	WO2004106331A1 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
12/09/2004	WO2004106328A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106315A2 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
12/09/2004	WO2004106305A1 New p2x7 receptor antagonists and their use
12/09/2004	WO2004106302A1 Novel substituted 3-sulfur indoles
12/09/2004	WO2004106294A2 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
12/09/2004	WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	WO2004105488A1 Hydrazone derivatives for combatting harmful insects and arachnids
12/09/2004	WO2004094388A3 Indazole derivatives as jnk inhibitors
12/09/2004	WO2004061084A8 Modulation of protein functionalities
12/09/2004	US20040249150 Positive allosteric modulators of the nicotinic acetylcholine receptor
12/09/2004	US20040248963 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
12/09/2004	US20040248950 Apo ai expression accelerating agent
12/09/2004	US20040248938 Substituted piperidines
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands
12/09/2004	US20040248890 Voltage gated sodium and calcium channel inhibitors
12/09/2004	US20040248887 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
12/09/2004	US20040248883 Novel heteroaryl derivatives, their preparation and use
12/09/2004	US20040248882 Noninsulin dependent diabetes, obesity, hypercholesterolemia, inflammatory disorders; reduced side effects; such as 5-(4-acetylbenzenesulfonamido-2-fluorophenoxy)-3-chloropyridine
12/09/2004	US20040248853 Antiinflammatory agents; antihistamines; adult respiratory distress syndrome; antidiabetic agents; inflammatory bowel disorders
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	CA2527583A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	CA2527197A1 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
12/09/2004	CA2527159A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	CA2526712A1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
12/08/2004	EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004	EP1484301A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
12/08/2004	EP1483262A1 Coumarines useful as biomarkers
12/08/2004	EP1483261A1 Phthalimide carboxylic acid derivatives
12/08/2004	EP1483259A1 Pyrimidines as novel openers of potassium ion channels
12/08/2004	EP1483240A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity
12/08/2004	EP1482957A1 Antibiotic conjugates
12/08/2004	EP1482944A2 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482930A1 Peptide deformylase inhibitors
12/08/2004	EP1482929A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178934C Benzofurane derivatives
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828340 Especially for cancer which has developed a multidrug-resistant phenotype.
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828325 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression
12/07/2004	US6828320 Heterocyclic compounds
12/07/2004	US6828116 Energy transfer assay method and reagent
12/07/2004	CA2272136C Pyrazole derivatives having crf antagonist activity
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004103998A1 Quinoline derivatives as phosphodiesterase inhibitors
12/02/2004	WO2004103995A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 647